Tower Research Capital (TRC)’s MEDASSETS INC COM STK (DE) MDAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-766
Closed -$24K – 5684
2015
Q4
$24K Buy
+766
New +$21.3K ﹤0.01% 1135
2015
Q3
– Sell
-2,955
Closed -$65K – 5448
2015
Q2
$65K Sell
2,955
-1,024
-26% -$21.4K 0.01% 1171
2015
Q1
$75K Buy
+3,979
New +$75.7K 0.01% 1146
2014
Q4
– Sell
-8,523
Closed -$177K – 5291
2014
Q3
$177K Buy
+8,523
New +$191K 0.02% 579
2014
Q2
– Sell
-97
Closed -$2K – 5156
2014
Q1
$2K Sell
97
-357
-79% -$8.04K ﹤0.01% 4003
2013
Q4
$9K Sell
454
-4,379
-91% -$98.5K ﹤0.01% 3139
2013
Q3
$123K Buy
+4,833
New +$108K 0.01% 1114

Tower Research Capital (TRC)'s MDAS Position: Q1 2016 in Review

Tower Research Capital (TRC) sold out of MEDASSETS INC COM STK (DE) (MDAS) in Q1 2016, closing a stake of 766 shares — an estimated $24K sold.

Tower Research Capital (TRC) first reported a position in MDAS in Q3 2013 and held it in 7 quarters. The position peaked at $177K in Q3 2014. 0 funds tracked by Wall St. Rank hold MDAS as of Q1 2016.

  • Tower Research Capital (TRC) reported no remaining MEDASSETS INC COM STK (DE) position as of Q1 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 766 MEDASSETS INC COM STK (DE) shares in Q1 2016, an estimated $24K.
  • Tower Research Capital (TRC) first reported a position in MEDASSETS INC COM STK (DE) in Q3 2013 and held it in 7 quarters.
  • Tower Research Capital (TRC)'s MEDASSETS INC COM STK (DE) position peaked at $177K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held MEDASSETS INC COM STK (DE) as of Q1 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2016, filed 16 May 2016.